Bone Research, 2022 · DOI: https://doi.org/10.1038/s41413-022-00188-y · Published: October 11, 2022
Neurogenic heterotopic ossifications (NHOs) are pathological heterotopic bones that develop in peri-articular muscles following severe lesions of the central nervous system, such as spinal cord injuries (SCIs). NHOs are frequent, with an incidence of 10%–23% in patients with traumatic brain injury and 10%–53% in patients with SCIs, increasing to 68% in victims of severe combat blast injuries involving the spine. Adult skeletal muscles contain two populations of stem/progenitor cells: (1) satellite cells (SCs), residing within the myofiber under the myofiber basal lamina, which regenerate myoblasts and myocytes following injury and are as such true muscle stem cells, and (2) fibroadipogenic progenitors (FAPs) residing in the interstitial space between myofibers. Following muscle injury, SCI causes the upregulation of PDGFRα expression on FAPs but not SCs and the failure of SCs to regenerate myofibers in the injured muscle, with reduced apoptosis and continued proliferation of muscle resident FAPs enabling their osteogenic differentiation into NHOs.
Identifying FAPs as the source of NHOs opens possibilities for targeted therapies to prevent or treat NHO development after SCI.
The study highlights the role of SCI in reprogramming FAPs, providing insights into the complex interplay between the nervous system and musculoskeletal system after injury.
The findings suggest that interventions aimed at modulating FAP activity, such as targeting PDGFRα signaling or promoting FAP apoptosis, could reduce NHO formation and improve outcomes for SCI patients.